Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
Annals of Oncology.
Times cited: 25
Persistently perplexing purpuras: Thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura .
Annals of Internal Medicine.
Times cited: 2